Charles Schwab’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $334M | Buy |
3,693,034
+135,946
| +4% | +$11.4M | 0.04% | 327 |
|
|
2026
Q1 | $285M | Buy |
3,557,088
+109,048
| +3% | +$8.99M | 0.04% | 320 |
|
|
2025
Q4 | $294M | Sell |
3,448,040
-5,048
| -0.1% | -$414K | 0.05% | 322 |
|
|
2025
Q3 | $269M | Sell |
3,453,088
-583,749
| -14% | -$45.6M | 0.04% | 335 |
|
|
2025
Q2 | $316M | Buy |
4,036,837
+89,027
| +2% | +$6.64M | 0.05% | 283 |
|
|
2025
Q1 | $286M | Buy |
3,947,810
+185,049
| +5% | +$13.2M | 0.05% | 287 |
|
|
2024
Q4 | $279M | Buy |
3,762,761
+103,659
| +3% | +$7.26M | 0.05% | 291 |
|
|
2024
Q3 | $241M | Buy |
3,659,102
+53,181
| +1% | +$3.86M | 0.05% | 323 |
|
|
2024
Q2 | $333M | Buy |
3,605,921
+31,349
| +0.9% | +$2.78M | 0.06% | 258 |
|
|
2024
Q1 | $342M | Buy |
3,574,572
+125,718
| +4% | +$10.6M | 0.08% | 225 |
|
|
2023
Q4 | $263M | Buy |
3,448,854
+5,669
| +0.2% | +$394K | 0.07% | 261 |
|
|
2023
Q3 | $239M | Buy |
3,443,185
+104,382
| +3% | +$8.39M | 0.07% | 252 |
|
|
2023
Q2 | $315M | Buy |
3,338,803
+6,467
| +0.2% | +$562K | 0.09% | 197 |
|
|
2023
Q1 | $276M | Buy |
3,332,336
+62,350
| +2% | +$4.9M | 0.08% | 208 |
|
|
2022
Q4 | $244M | Buy |
3,269,986
+122,607
| +4% | +$9.45M | 0.08% | 230 |
|
|
2022
Q3 | $260M | Sell |
3,147,379
-9,269
| -0.3% | -$892K | 0.09% | 195 |
|
|
2022
Q2 | $300M | Buy |
3,156,648
+51,520
| +2% | +$5.33M | 0.1% | 181 |
|
|
2022
Q1 | $366M | Buy |
3,105,128
+80,881
| +3% | +$9.07M | 0.11% | 166 |
|
|
2021
Q4 | $392M | Buy |
3,024,247
+85,550
| +3% | +$9.98M | 0.12% | 159 |
|
|
2021
Q3 | $333M | Buy |
2,938,697
+59,772
| +2% | +$6.82M | 0.11% | 164 |
|
|
2021
Q2 | $298M | Buy |
2,878,925
+18,383
| +0.6% | +$1.73M | 0.1% | 181 |
|
|
2021
Q1 | $239M | Sell |
2,860,542
-259,457
| -8% | -$21.9M | 0.09% | 199 |
|
|
2020
Q4 | $285M | Sell |
3,119,999
-239,279
| -7% | -$19.8M | 0.11% | 167 |
|
|
2020
Q3 | $268M | Sell |
3,359,278
-64,985
| -2% | -$5.07M | 0.12% | 150 |
|
|
2020
Q2 | $237M | Buy |
3,424,263
+170,523
| +5% | +$12.1M | 0.12% | 167 |
|
|
2020
Q1 | $205M | Buy |
3,253,740
+64,089
| +2% | +$4.62M | 0.12% | 159 |
|
|
2019
Q4 | $248M | Buy |
3,189,651
+239,235
| +8% | +$18.7M | 0.13% | 142 |
|
|
2019
Q3 | $216M | Buy |
2,950,416
+64,569
| +2% | +$4.54M | 0.13% | 151 |
|
|
2019
Q2 | $178M | Sell |
2,885,847
-67,410
| -2% | -$4.08M | 0.11% | 178 |
|
|
2019
Q1 | $188M | Buy |
2,953,257
+452,181
| +18% | +$25.8M | 0.12% | 154 |
|
|
2018
Q4 | $128M | Buy |
2,501,076
+62,175
| +3% | +$3.15M | 0.1% | 186 |
|
|
2018
Q3 | $142M | Buy |
2,438,901
+54,900
| +2% | +$2.69M | 0.09% | 189 |
|
|
2018
Q2 | $116M | Buy |
2,384,001
+79,038
| +3% | +$3.69M | 0.08% | 219 |
|
|
2018
Q1 | $107M | Buy |
2,304,963
+133,467
| +6% | +$5.8M | 0.08% | 230 |
|
|
2017
Q4 | $81.6M | Buy |
2,171,496
+86,463
| +4% | +$3.17M | 0.06% | 285 |
|
|
2017
Q3 | $76M | Buy |
2,085,033
+109,269
| +6% | +$4.17M | 0.07% | 285 |
|
|
2017
Q2 | $77.9M | Buy |
1,975,764
+58,470
| +3% | +$2.13M | 0.07% | 269 |
|
|
2017
Q1 | $60.1M | Buy |
1,917,294
+102,276
| +6% | +$3.2M | 0.06% | 310 |
|
|
2016
Q4 | $56.7M | Sell |
1,815,018
-108,924
| -6% | -$3.53M | 0.06% | 304 |
|
|
2016
Q3 | $77.3M | Buy |
1,923,942
+132,012
| +7% | +$4.97M | 0.09% | 223 |
|
|
2016
Q2 | $59.6M | Sell |
1,791,930
-35,055
| -2% | -$1.2M | 0.07% | 270 |
|
|
2016
Q1 | $53.7M | Buy |
1,826,985
+24,597
| +1% | +$679K | 0.07% | 285 |
|
|
2015
Q4 | $47.5M | Buy |
1,802,388
+85,176
| +5% | +$2.21M | 0.06% | 295 |
|
|
2015
Q3 | $40.7M | Sell |
1,717,212
-275,658
| -14% | -$6.65M | 0.06% | 306 |
|
|
2015
Q2 | $47.3M | Sell |
1,992,870
-375,564
| -16% | -$8.48M | 0.07% | 288 |
|
|
2015
Q1 | $56.2M | Sell |
2,368,434
-99,048
| -4% | -$2.22M | 0.08% | 251 |
|
|
2014
Q4 | $52.4M | Buy |
2,467,482
+150,384
| +6% | +$3.02M | 0.08% | 248 |
|
|
2014
Q3 | $39.4M | Buy |
2,317,098
+841,416
| +57% | +$13.3M | 0.06% | 283 |
|
|
2014
Q2 | $21.1M | Buy |
1,475,682
+32,874
| +2% | +$446K | 0.04% | 471 |
|
|
2014
Q1 | $17.8M | Buy |
1,442,808
+20,334
| +1% | +$235K | 0.03% | 505 |
|
|
2013
Q4 | $15.6M | Buy |
1,422,474
+55,434
| +4% | +$625K | 0.03% | 513 |
|
|
2013
Q3 | $16.2M | Buy |
1,367,040
+38,610
| +3% | +$452K | 0.03% | 462 |
|
|
2013
Q2 | $14.8M | Buy |
+1,328,430
| New | +$15.7M | 0.03% | 459 |
|
Other funds holding EW
Charles Schwab's EW Position: Q2 2026 in Review
Charles Schwab increased its Edwards Lifesciences (EW) stake by 3.8% in Q2 2026, buying an estimated $11.4M and bringing the position to 3,693,034 shares worth $334M. The position accounts for 0.04% of the portfolio, ranked #327.
Charles Schwab first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $392M in Q4 2021. 1,328 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Charles Schwab held 3,693,034 shares of Edwards Lifesciences worth $334M as of Q2 2026.
- Charles Schwab bought 135,946 Edwards Lifesciences shares in Q2 2026, an estimated $11.4M.
- Edwards Lifesciences made up 0.04% of Charles Schwab's portfolio in Q2 2026, its #327 holding.
- Charles Schwab first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Edwards Lifesciences position peaked at $392M in Q4 2021.
- 1,328 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.